drugMR: A multi-omics pipeline for genetically anchored drug-target discovery
DrugMR is a Nextflow pipeline that runs cis-Mendelian randomisation, colocalisation, SMR-HEIDI with bulk and/or single-cell QTLs, three-trait colocalisation and a phenome-wide screen for adverse effects and repurposing, applied to schizophrenia with brain pQTLs.